SGS Invests in New E&L Laboratory in India
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
SGS announced on Oct. 12, 2021, that it is investing in a new extractables and leachables (E&L) testing laboratory in Navi Mumbai, India. The lab is set to open by the end of 2021 and will provide testing services for verifying product safety for pharmaceutical, biopharmaceutical, and medical device companies in Southeast Asia.
The new lab will be approximately 3000 ft.2 and will offer a broad spectrum of the latest E&L testing solutions, including:
- gas chromatography–mass spectrometry (GC–MS) and headspace–GC/MS for the analysis of semi-volatile and volatile components
- liquid chromatography with tandem mass spectrometry (LC–MSMS) for the quantitative analysis of trace leachable components
- high resolution LC–MSMS to generate data that supports identification of unknown components
- and inductively coupled plasma–MS to quantitate screening and identification of inorganics.
This laboratory in India will complement SGS's existing testing network. The company has three other E&L centers of excellence located in the United States, Germany, and China.
Source: SGS
Ushering in Industry 4.0 with the IDMO Model to Solve the CGT Manufacturing Bottleneck
May 28th 2025Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be accomplished with smart factories that utilize fully automated manufacturing platforms.
Novel Modalities Spur Shift in Outsourcing Processes and Partnerships
May 8th 2025While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
